Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study

Julie Laniel,Serge Sultan,Daniel Sinnett,Caroline Laverdière,Maja Krajinovic,Philippe Robaey,Luc Duong,Sarah Lippé

DOI: https://doi.org/10.3390/cancers16061208

2024-03-20

Cancers

Abstract:Acute lymphoblastic leukemia (ALL) stands as the most prevalent form of pediatric cancer in North America, with a current five-year survival rate of 85%. While more children achieved ALL remission and transition into adulthood, the prevalence of long-term treatment-related effects, especially neurocognitive sequelae, remains significant. This study pursues two objectives. Firstly, it investigates if Magnetization Transfer Ratio (MTR), a method assessing myelin integrity, is sensitive to white matter (WM) microstructural changes in long-term ALL survivors and whether these relate to cognitive impairments. Secondly, it examines the dose-related effects of chemotherapy agents on the MTR and its relationship to other risk factors such as female sex, early age diagnosis, and cranial radiotherapy. Magnetization transfer imaging was utilized to assess WM integrity in 35 survivors at a mean of 18.9 years after the onset of ALL (range since diagnosis: 6.9–26.8). Additionally, 21 controls matched for age, sex, and education level, with no history of cancer, were included. MTR was extracted from both the entire brain's WM and the corpus callosum through semi-automated procedures. The results indicated lower MTR means in survivors, which is linked to cognitive function. Negative associations between MTR means and intrathecal agents' (MTX, cytarabine, and hydrocortisone) cumulative doses received were highlighted. This study offers valuable insights into the connections between myelin deterioration, cognitive impairment, and the implications of IT chemotherapy, enhancing our understanding of ALL survivorship dynamics. It underscores MTR's relevance in monitoring neurotoxicity during oncological drug follow-up examinations.

oncology

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

This paper aims to explore the relationship between the integrity of white matter in long-term survivors of acute lymphoblastic leukemia (ALL) and the dosage of chemotherapy, particularly the impact of intrathecal chemotherapy drugs on white matter integrity. Specifically, the study has two main objectives:

1. **To evaluate whether the magnetization transfer ratio (MTR) can detect microstructural changes in the white matter of long-term ALL survivors and determine if these changes are related to cognitive dysfunction.**
- The magnetization transfer ratio (MTR) is a method for assessing myelin integrity and can detect microstructural changes in white matter.
- Researchers hope to use MTR to detect changes in the white matter of ALL survivors and explore whether these changes are related to cognitive dysfunction.

2. **To examine the impact of the cumulative dose of chemotherapy drugs on MTR and its relationship with other risk factors (such as female gender, early age at diagnosis, and cranial radiation therapy).**
- Researchers are particularly focused on the impact of the cumulative dose of intrathecal chemotherapy drugs (such as methotrexate, cytarabine, and hydrocortisone) on MTR.
- Additionally, the study considers other risk factors, such as female gender, early age at diagnosis, and cranial radiation therapy, to comprehensively understand their impact on white matter integrity.

Through these two objectives, the study hopes to enhance the understanding of the long-term quality of life of ALL survivors and emphasize the importance of MTR in monitoring neurotoxicity during and after cancer treatment.